Fingerprint
Dive into the research topics of 'Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells
Wei Cheng Wu, Yi Min Liu, Yu Hsuan Liao, Kai Cheng Hsu, Ssu Ting Lien, I. Chung Chen, Mei Jung Lai, Yu Hsuan Li, Shiow Lin Pan, Mei Chuan Chen, Jing Ping Liou
- School of Pharmacy
- TMU Research Center of Drug Discovery
- College of Medical Science and Technology
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- Taipei Medical University Hospital
- Department of Pharmaceutical Sciences
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- Graduate Institute of Pharmacognosy
- Master Program in Clinical Genomics and Proteomics
- International Ph.D. Program for Translational Science
- TMU Research Center of Cancer Translational Medicine
Research output: Contribution to journal › Article › peer-review
9
Citations
(Scopus)